Literature DB >> 16804441

Norovirus-associated encephalopathy.

Shuichi Ito1, Saoko Takeshita, Atsuo Nezu, Yukoh Aihara, Shuzo Usuku, Yuzo Noguchi, Shumpei Yokota.   

Abstract

Norovirus is a common cause of gastroenteritis. We describe the case of a 23-month-old girl with encephalopathy possibly associated with norovirus infection. The viral genome was detected in stool, serum and cerebrospinal fluid (CSF) by reverse transcription polymerase chain reaction. This is the first report of encephalopathy potentially caused by norovirus as indicated by the presence of the virus genome in CSF.

Entities:  

Mesh：

Year:  2006        PMID： 16804441     DOI： 10.1097/01.inf.0000225789.92512.6d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  19 in total

1.  Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses.

Authors:  Shannon M Mumphrey; Harish Changotra; Tara N Moore; Ellen R Heimann-Nichols; Christiane E Wobus; Michael J Reilly; Mana Moghadamfalahi; Deepti Shukla; Stephanie M Karst
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 2.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  An adult norovirus-related encephalitis/encephalopathy with mild clinical manifestation.

Authors:  En Kimura; Hitomi Goto; Akie Migita; Seiya Harada; Satoshi Yamashita; Teruyuki Hirano; Makoto Uchino
Journal:  BMJ Case Rep       Date:  2010-10-18

4.  Type I and type II interferons inhibit the translation of murine norovirus proteins.

Authors:  Harish Changotra; Yali Jia; Tara N Moore; Guangliang Liu; Shannon M Kahan; Stanislav V Sosnovtsev; Stephanie M Karst
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.

Authors:  Joana Rocha-Pereira; Abimbola O Kolawole; Eric Verbeken; Christiane E Wobus; Johan Neyts
Journal:  Antiviral Res       Date:  2016-05-29       Impact factor: 5.970

6.  Co-detection in the pathogenesis of severe hand-foot-mouth disease.

Authors:  Li-Juan Liu; Hong-Mei Xu; Xiu-Jun Li; Jun Wang; Xian-Jun Wang; Shu-Jun Ding; Fang Tang; Jing Wang; Ying-Jie Zhang
Journal:  Arch Virol       Date:  2012-07-13       Impact factor: 2.574

7.  Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon.

Authors:  Armando Arias; Dalan Bailey; Yasmin Chaudhry; Ian Goodfellow
Journal:  J Gen Virol       Date:  2012-04-11       Impact factor: 3.891

8.  The estimated disease burden of norovirus in The Netherlands.

Authors:  L Verhoef; M Koopmans; W VAN Pelt; E Duizer; J Haagsma; D Werber; L VAN Asten; A Havelaar
Journal:  Epidemiol Infect       Date:  2012-05-17       Impact factor: 4.434

9.  Pathogenesis of noroviruses, emerging RNA viruses.

Authors:  Stephanie M Karst
Journal:  Viruses       Date:  2010-03-23       Impact factor: 5.818

10.  Acute liver dysfunction in the course of norovirus gastroenteritis.

Authors:  H Nakajima; T Watanabe; T Miyazaki; M Takeuchi; Y Honda; N Shimada; K Nakanishi; Y Urita; M Sugimoto
Journal:  Case Rep Gastroenterol       Date:  2012-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.